Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 controlled study

cT1 showed superior reproducibility (CoV 3.1%) compared to the other non-invasive liver tests used in this NASH clinical trial: magnetic resonance elastography (MRE, CoV 11%) and transient elastography (TE, 40%). This underscores utility of cT1 as a sensitive, reliable marker for monitoring longitudinal change in NASH patients.